Clinical Trials

DLBCL clinical trials are both a treatment option for all types of patients and the core way that new advances are made in DLBCL care. Learn more about these clinical trials.

Recent Articles

MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants

October 16, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.

The FDA Approves Columvi For Relapsed/Refractory DLBCL

October 08, 2023

The Food and Drug Administration (FDA) approved Columvi (glofitamab-gxbm) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Tax ID 45-5354811

Clinical Trials

Recent Articles

Get the latest thought leadership on Diffuse Large B Cell Lymphoma delivered straight to your inbox.

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors: